BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24646991)

  • 1. Cell biology: The disassembly of death.
    Gregory CD
    Nature; 2014 Mar; 507(7492):312-3. PubMed ID: 24646991
    [No Abstract]   [Full Text] [Related]  

  • 2. Unexpected link between an antibiotic, pannexin channels and apoptosis.
    Poon IK; Chiu YH; Armstrong AJ; Kinchen JM; Juncadella IJ; Bayliss DA; Ravichandran KS
    Nature; 2014 Mar; 507(7492):329-34. PubMed ID: 24646995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemifloxacin for community-acquired pneumonia.
    Lode HM; Schmidt-Ionas M; Stahlmann R
    Expert Opin Investig Drugs; 2008 May; 17(5):779-86. PubMed ID: 18447602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolones in the management of community-acquired pneumonia in primary care.
    Wispelwey B; Schafer KR
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1259-71. PubMed ID: 21073291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
    Blondeau JM; Tillotson G
    Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A probable association of acute dystonia with gemifloxacin administration.
    Sharma DD; Aggarwal A; Sharma RC; Kumar R
    Indian J Med Sci; 2009 Dec; 63(12):557-60. PubMed ID: 20160381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cause of acute hepatitis: gemifloxacin.
    Kilincalp S; Deveci M; Coban S; Basar O; Yuksel O
    Acta Gastroenterol Belg; 2012 Dec; 75(4):460-1. PubMed ID: 23402094
    [No Abstract]   [Full Text] [Related]  

  • 8. When antibiotics turn toxic.
    Marchant J
    Nature; 2018 Mar; 555(7697):431-433. PubMed ID: 29565407
    [No Abstract]   [Full Text] [Related]  

  • 9. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
    Hooper DC; Wolfson JS
    Antimicrob Agents Chemother; 1985 Nov; 28(5):716-21. PubMed ID: 2936302
    [No Abstract]   [Full Text] [Related]  

  • 10. A quantized mechanism for activation of pannexin channels.
    Chiu YH; Jin X; Medina CB; Leonhardt SA; Kiessling V; Bennett BC; Shu S; Tamm LK; Yeager M; Ravichandran KS; Bayliss DA
    Nat Commun; 2017 Jan; 8():14324. PubMed ID: 28134257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will fluoroquinolones ever be recommended for common infections in children?
    Schaad UB
    Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Pawlak J; Belian B
    Int J Antimicrob Agents; 2005 Jul; 26(1):81-4. PubMed ID: 15951159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSAC Respiratory Resistance Surveillance Programme (2002-2003): comparative susceptibility of Streptococcus pneumoniae, cultured from patients in Great Britain and Ireland with community-acquired lower respiratory tract infection, to gemifloxacin.
    Felmingham D; Shackcloth J; Tillotson G
    J Antimicrob Chemother; 2004 Sep; 54(3):698-9. PubMed ID: 15294888
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemifloxacin (factive).
    Med Lett Drugs Ther; 2004 Sep; 46(1192):78-9. PubMed ID: 15452464
    [No Abstract]   [Full Text] [Related]  

  • 16. The newer fluoroquinolones.
    Bolon MK
    Infect Dis Clin North Am; 2009 Dec; 23(4):1027-51, x. PubMed ID: 19909896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical and pharmacoeconomic aspects of gemifloxacin(corrected) use in the patients with extra-hospital pneumonia in stationary conditions].
    Zaĭtsev AA; Sinopal'nikova AI
    Voen Med Zh; 2007 Jan; 328(1):44-51. PubMed ID: 17436714
    [No Abstract]   [Full Text] [Related]  

  • 18. Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.
    Ross JE; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):219-21. PubMed ID: 15766610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone antibiotics in infants and children.
    Schaad UB
    Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
    Kim J; Ohtani H; Tsujimoto M; Sawada Y
    Drug Metab Pharmacokinet; 2009; 24(2):167-74. PubMed ID: 19430173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.